An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy
Journal of Atherosclerosis and Thrombosis · 01.07.2026 · 33 (7) · 882-883
DOI: 10.5551/jat.ed302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.07.2026. Verfasst von Hayato Tada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa University. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa University.
Zitieren
APA
Tada, H., & Takamura, M. (2026). An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy. Journal of Atherosclerosis and Thrombosis, 33(7), 882-883. https://doi.org/10.5551/jat.ed302
Vancouver
Tada H, Takamura M. An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy. Journal of Atherosclerosis and Thrombosis. 2026;33(7):882-883. doi:10.5551/jat.ed302
BibTeX
@article{Tada2026,
author = {Tada, Hayato and Takamura, Masayuki},
title = {An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
volume = {33},
number = {7},
pages = {882--883},
doi = {10.5551/jat.ed302}
}
EUVIMED